CCSA’s Issues of Substance Conference
Back

Oral Presentation F6
Opioid Agonist Therapy: Interventions, Barriers and Guidelines

Date & Time Tuesday, November 26
3:45 - 5:15

Add to Calendar

F6.1 Identifying Barriers of Access and Retention in Opioid Agonist Treatment in British Columbia 

Kristi Papamihali, British Columbia Centre for Disease Control
Brittany Graham, British Columbia Centre for Disease Control
Christopher Mill, British Columbia Centre for Disease Control
Mohammad Karamouzian, University of British Columbia
Alexis Crabtree, British Columbia Centre for Disease Control
Sara Young, British Columbia Centre for Disease Control
Jane A. Buxton, British Columbia Centre for Disease Control

F6.2 Evaluating Comparative Effectiveness of Psychosocial Interventions Adjunctive to Opioid Agonist Therapy: A Systematic Review and Network Meta-Analysis 

Kim Corace, Royal Ottawa Mental Health Centre
Danielle Rice, Ottawa Hospital Research Institute
Patricia Poulin, Ottawa Hospital Research Institute
Beth Sproule, Centre for Addiction and Mental Health
David Moher, Ottawa Hospital Research Institute
Gary Garber, Public Health Ontario
Sheena Taha, Canadian Centre on Substance Use and Addiction
Amy Porath, Canadian Centre on Substance Use and Addiction
Melanie Willows, Royal Ottawa Mental Health Centre
Leila Esmaeilisaraji, Ottawa Hospital Research Institute
Fatemeh Yazadi, Ottawa Hospital Research Institute
Bradley Austin, Ottawa Hospital Research Institute
Alicia Grima, Ottawa Hospital Research Institute
Reuben Douma, Ottawa Hospital Research Institute
Gord Garner, The Community Addictions Peer Support Association
Donna May, moms united and mandated to saving the lives of Drug Users
Kednapa Thavorn, Ottawa Hospital Research Institute
Pauline Barbeau, Ottawa Hospital Research Institute
Dianna Wolfe, Ottawa Hospital Research Institute
Bev Shea, Ottawa Hospital Research Institute
Becky Skidmore, Ottawa Hospital Research Institute
Mistry Pratt, Ottawa Hospital Research Institute
Brian Hutton, Ottawa Hospital Research Institute

F6.3 Opioid-Agonist Therapy (OAT) Guidelines for First Nations Community-Based Programs and NNADAP/NYSAP Residential Treatment Programs: A Canadian Research Initiative on Substance Misuse 

Rachel Maskell, Thunderbird Partnership Foundation
Carol Hopkins, Thunderbird Partnership Foundation
Christopher Musquash, Lakehead University



 

We use cookies to ensure that we give you the best experience possible on our website.

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.